DrugPatentWatch Database Preview
Drugs in MeSH Category Cytochrome P-450 CYP3A Inducers
» See Plans and Pricing
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Taro | CARBAMAZEPINE | carbamazepine | CAPSULE, EXTENDED RELEASE;ORAL | 201106-002 | Jun 21, 2013 | AB | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| Taro | CARBAMAZEPINE | carbamazepine | TABLET, EXTENDED RELEASE;ORAL | 078115-002 | Mar 31, 2009 | AB | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| Sanofi Aventis Us | RIFADIN | rifampin | CAPSULE;ORAL | 062303-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| Unique Pharm | CARBAMAZEPINE | carbamazepine | TABLET, EXTENDED RELEASE;ORAL | 211623-001 | Apr 24, 2020 | AB | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| Tech Organized | NEVIRAPINE | nevirapine | TABLET, EXTENDED RELEASE;ORAL | 207467-001 | Jul 31, 2017 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
